BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ma S, Goh EL, Jin A, Bhattacharya R, Boughton OR, Patel B, Karunaratne A, Vo NT, Atwood R, Cobb JP, Hansen U, Abel RL. Long-term effects of bisphosphonate therapy: perforations, microcracks and mechanical properties. Sci Rep 2017;7:43399. [PMID: 28262693 DOI: 10.1038/srep43399] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 8.8] [Reference Citation Analysis]
Number Citing Articles
1 Rodionova SS, Kolondaev AF, Torgashin AN, Solomyannik IA. Zoledronic acid for osteoporosis and associated low-energy fractures. Medicinskij sovet 2022. [DOI: 10.21518/2079-701x-2022-16-21-163-173] [Reference Citation Analysis]
2 Esteban-lopez M, Wilson KJ, Myhr C, Kaftanovskaya EM, Henderson MJ, Southall NT, Xu X, Wang A, Hu X, Barnaeva E, Ye W, George ER, Sherrill JT, Ferrer M, Morello R, Agoulnik IU, Marugan JJ, Agoulnik AI. Discovery of small molecule agonists of the Relaxin Family Peptide Receptor 2. Commun Biol 2022;5:1183. [DOI: 10.1038/s42003-022-04143-9] [Reference Citation Analysis]
3 Pienkowski D, Wood CL, Malluche HH. Trabecular bone microcrack accumulation in patients treated with bisphosphonates for durations up to 16 years. J Orthop Res 2022. [PMID: 36163612 DOI: 10.1002/jor.25441] [Reference Citation Analysis]
4 Navarro-Gonzalez E. Use of multikinase inhibitors/lenvatinib concomitant with antiresorptive therapy for bone metastases from radioiodine-resistant differentiated thyroid cancer. Cancer Med 2022. [PMID: 35785524 DOI: 10.1002/cam4.4983] [Reference Citation Analysis]
5 Bradaschia-Correa V, Ribeiro-Santos GC, de Faria LP, Rezende-Teixeira P, Arana-Chavez VE. Inhibition of osteoclastogenesis after bisphosphonate therapy discontinuation: an in vitro approach. J Mol Histol 2022. [PMID: 35701706 DOI: 10.1007/s10735-022-10083-9] [Reference Citation Analysis]
6 Gu L, Gong T, Ma Q, Zhong D. Retrospective study of EGFR-mutant lung adenocarcinoma with bone metastatic clinical features. Cancer Rep (Hoboken) 2022;:e1628. [PMID: 35614541 DOI: 10.1002/cnr2.1628] [Reference Citation Analysis]
7 Openshaw PJM. Using correlates to accelerate vaccinology. Science 2022;375:22-3. [PMID: 34990231 DOI: 10.1126/science.abn0007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
8 Jeon H, Yu J, Hwang JM, Park H, Yu J, Lee Z, Kim T, Rho J. 1,3-Dibenzyl-5-Fluorouracil Prevents Ovariectomy-Induced Bone Loss by Suppressing Osteoclast Differentiation. Immune Netw 2022;22. [DOI: 10.4110/in.2022.22.e43] [Reference Citation Analysis]
9 Naruphontjirakul P, Li S, Pinna A, Barrak F, Chen S, Redpath AN, Rankin SM, Porter AE, Jones JR. Interaction of monodispersed strontium containing bioactive glass nanoparticles with macrophages. Mater Sci Eng C Mater Biol Appl 2021;:112610. [PMID: 35042635 DOI: 10.1016/j.msec.2021.112610] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Gremminger VL, Phillips CL. Impact of Intrinsic Muscle Weakness on Muscle-Bone Crosstalk in Osteogenesis Imperfecta. Int J Mol Sci 2021;22:4963. [PMID: 34066978 DOI: 10.3390/ijms22094963] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Abel RL, Stavri R, Gray M, Hansen U. Clinical Importance of Bone Matrix Damage Mechanisms for Fracture Prevention. Curr Osteoporos Rep 2021;19:318-26. [PMID: 33876386 DOI: 10.1007/s11914-021-00678-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Schoenhof R, Munz A, Yuan A, ElAyouti A, Boesmueller H, Blumenstock G, Reinert S, Hoefert S. Microarchitecture of medication-related osteonecrosis of the jaw (MRONJ); a retrospective micro-CT and morphometric analysis. J Craniomaxillofac Surg 2021;49:508-17. [PMID: 33707134 DOI: 10.1016/j.jcms.2021.02.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Connolley T, Beavers CM, Chater P. High-Energy Adventures at Diamond Light Source. Synchrotron Radiation News 2020;33:31-6. [DOI: 10.1080/08940886.2020.1841494] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
14 Chang S, Doshi AH, Gibbs WN, Finkelstein M, Deutsch J, De Leacy RA. Sacral Augmentation: Comprehensive Review. Image Guided Interventions of the Spine 2021. [DOI: 10.1007/978-3-030-80079-6_8] [Reference Citation Analysis]
15 Abeynayake N, Arthur A, Gronthos S. Crosstalk between skeletal and neural tissues is critical for skeletal health. Bone 2021;142:115645. [PMID: 32949783 DOI: 10.1016/j.bone.2020.115645] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
16 Burr DB. Fifty years of bisphosphonates: What are their mechanical effects on bone? Bone 2020;138:115518. [DOI: 10.1016/j.bone.2020.115518] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
17 Monzem S, Ballester RY, Javaheri B, Poulet B, Sônego DA, Pitsillides AA, Souza RL. Long-term bisphosphonate treatment coupled with ovariectomy in mice provokes deleterious effects on femoral neck fracture pattern and modifies tibial shape. Bone Jt Open 2020;1:512-9. [PMID: 33215149 DOI: 10.1302/2633-1462.19.BJO-2020-0117.R1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
18 Pfeilschifter J, Steinebach I, Trampisch HJ, Rudolf H. Bisphosphonate drug holidays: Risk of fractures and mortality in a prospective cohort study. Bone 2020;138:115431. [DOI: 10.1016/j.bone.2020.115431] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
19 Gambari L, Grassi F, Roseti L, Grigolo B, Desando G. Learning from Monocyte-Macrophage Fusion and Multinucleation: Potential Therapeutic Targets for Osteoporosis and Rheumatoid Arthritis. Int J Mol Sci 2020;21:E6001. [PMID: 32825443 DOI: 10.3390/ijms21176001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
20 Sequeira L, Nguyen J, Wang L, Nohe A. A Novel Peptide, CK2.3, Improved Bone Formation in Ovariectomized Sprague Dawley Rats. Int J Mol Sci 2020;21:E4874. [PMID: 32664215 DOI: 10.3390/ijms21144874] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
21 Milovanovic P, Busse B. Inter-site Variability of the Human Osteocyte Lacunar Network: Implications for Bone Quality. Curr Osteoporos Rep 2019;17:105-15. [PMID: 30980284 DOI: 10.1007/s11914-019-00508-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
22 Cai X, Peralta L, Brenner R, Iori G, Cassereau D, Raum K, Laugier P, Grimal Q. Anisotropic elastic properties of human cortical bone tissue inferred from inverse homogenization and resonant ultrasound spectroscopy. Materialia 2020;11:100730. [DOI: 10.1016/j.mtla.2020.100730] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
23 Xie W, Li F, Han Y, Qin Y, Wang Y, Chi X, Xiao J, Li Z. Neuropeptide Y1 receptor antagonist promotes osteoporosis and microdamage repair and enhances osteogenic differentiation of bone marrow stem cells via cAMP/PKA/CREB pathway. Aging (Albany NY) 2020;12:8120-36. [PMID: 32381754 DOI: 10.18632/aging.103129] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
24 Steczina S, Tahimic CGT, Pendleton M, M'Saad O, Lowe M, Alwood JS, Halloran BP, Globus RK, Schreurs AS. Dietary countermeasure mitigates simulated spaceflight-induced osteopenia in mice. Sci Rep 2020;10:6484. [PMID: 32300161 DOI: 10.1038/s41598-020-63404-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
25 Maenz S, Brinkmann O, Hasenbein I, Braun C, Kunisch E, Horbert V, Gunnella F, Sachse A, Bischoff S, Schubert H, Jandt KD, Bossert J, Driesch D, Kinne RW, Bungartz M. The old sheep: a convenient and suitable model for senile osteopenia. J Bone Miner Metab 2020;38:620-30. [PMID: 32296985 DOI: 10.1007/s00774-020-01098-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Urits I, Orhurhu V, Callan J, Maganty NV, Pousti S, Simopoulos T, Yazdi C, Kaye RJ, Eng LK, Kaye AD, Manchikanti L, Viswanath O. Sacral Insufficiency Fractures: a Review of Risk Factors, Clinical Presentation, and Management. Curr Pain Headache Rep 2020;24:10. [PMID: 32067155 DOI: 10.1007/s11916-020-0848-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
27 Wang JY, Huo L, Yu RQ, Rao NJ, Lu WW, Zheng LW. Skeletal Site-Specific Response of Jawbones and Long Bones to Surgical Interventions in Rats Treated with Zoledronic Acid. Biomed Res Int 2019;2019:5138175. [PMID: 31930124 DOI: 10.1155/2019/5138175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
28 Naruphontjirakul P, Tsigkou O, Li S, Porter AE, Jones JR. Human mesenchymal stem cells differentiate into an osteogenic lineage in presence of strontium containing bioactive glass nanoparticles. Acta Biomater 2019;90:373-92. [PMID: 30910622 DOI: 10.1016/j.actbio.2019.03.038] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 17.7] [Reference Citation Analysis]
29 Bover J, Ureña-torres P, Laiz Alonso AM, Torregrosa J, Rodríguez-garcía M, Castro-alonso C, Górriz JL, Benito S, López-báez V, Lloret Cora MJ, Cigarrán S, Dasilva I, Sánchez-bayá M, Mateu Escudero S, Guirado L, Cannata-andía J. Osteoporosis, densidad mineral ósea y complejo CKD-MBD (II): implicaciones terapéuticas. Nefrología 2019;39:227-42. [DOI: 10.1016/j.nefro.2018.10.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
30 Bover J, Ureña-torres P, Laiz Alonso AM, Torregrosa J, Rodríguez-garcía M, Castro-alonso C, Górriz JL, Benito S, López-báez V, Lloret Cora MJ, Cigarrán S, Dasilva I, Sánchez-bayá M, Mateu Escudero S, Guirado L, Cannata-andía J. Osteoporosis, bone mineral density and CKD-MBD (II): Therapeutic implications. Nefrología (English Edition) 2019;39:227-42. [DOI: 10.1016/j.nefroe.2018.10.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
31 Cai X, Follet H, Peralta L, Gardegaront M, Farlay D, Gauthier R, Yu B, Gineyts E, Olivier C, Langer M, Gourrier A, Mitton D, Peyrin F, Grimal Q, Laugier P. Anisotropic elastic properties of human femoral cortical bone and relationships with composition and microstructure in elderly. Acta Biomater 2019;90:254-66. [PMID: 30922952 DOI: 10.1016/j.actbio.2019.03.043] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
32 Cook B, Rafiq R, Lee H, Banks KM, El-Debs M, Chiaravalli J, Glickman JF, Das BC, Chen S, Evans T. Discovery of a Small Molecule Promoting Mouse and Human Osteoblast Differentiation via Activation of p38 MAPK-β. Cell Chem Biol 2019;26:926-935.e6. [PMID: 31031140 DOI: 10.1016/j.chembiol.2019.03.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
33 Allen MR. Recent Advances in Understanding Bisphosphonate Effects on Bone Mechanical Properties. Curr Osteoporos Rep 2018;16:198-204. [PMID: 29497927 DOI: 10.1007/s11914-018-0430-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
34 Mathiesen IH, Hitz MF, Katzenstein TL, Oturai P, Skov M, Jørgensen NR, Jensen PO, Mikkelsen CR, Krogh-Madsen R, Pressler T, Faurholt-Jepsen D. Markers of bone turnover are reduced in patients with CF related diabetes; the role of glucose. J Cyst Fibros 2019;18:436-41. [PMID: 30928333 DOI: 10.1016/j.jcf.2019.01.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
35 Hu B, Wu H, Shi Z, Ying Z, Zhao X, Lin T, Hong J, Wang Y, Yang Y, Cai X, Yan S. Effects of sequential treatment with intermittent parathyroid hormone and zoledronic acid on particle-induced implant loosening: Evidence from a rat model. J Orthop Res 2019;37:1489-97. [PMID: 30644138 DOI: 10.1002/jor.24217] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Zhao S, Arnold M, Ma S, Abel RL, Cobb JP, Hansen U, Boughton O. Standardizing compression testing for measuring the stiffness of human bone. Bone Joint Res 2018;7:524-38. [PMID: 30258572 DOI: 10.1302/2046-3758.78.BJR-2018-0025.R1] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 12.0] [Reference Citation Analysis]
37 An Q, Gou B, Ma S, Goh EL, Liu G, Sah BK, Cao H. Icariin induces MC3T3-E1 cell proliferation and differentiation via the BMP-2/Smads/Runx2 signal pathway.. [DOI: 10.1101/405787] [Reference Citation Analysis]
38 Demirtas A, Ural A. Material heterogeneity, microstructure, and microcracks demonstrate differential influence on crack initiation and propagation in cortical bone. Biomech Model Mechanobiol 2018;17:1415-28. [PMID: 29808355 DOI: 10.1007/s10237-018-1035-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
39 Ohishi T, Matsuyama Y. Minodronate for the treatment of osteoporosis. Ther Clin Risk Manag 2018;14:729-39. [PMID: 29713181 DOI: 10.2147/TCRM.S149236] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
40 Ohishi T, Fujita T, Suzuki D, Nishida T, Asukai M, Matsuyama Y. Serum homocysteine levels are affected by renal function during a 3-year period of minodronate therapy in female osteoporotic patients. J Bone Miner Metab 2019;37:319-26. [PMID: 29603071 DOI: 10.1007/s00774-018-0920-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
41 Binkley N, Krueger D, de Papp AE. Multiple vertebral fractures following osteoporosis treatment discontinuation: a case-report after long-term Odanacatib. Osteoporos Int 2018;29:999-1002. [PMID: 29455249 DOI: 10.1007/s00198-018-4385-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
42 Gundry M, Hopkins S, Knapp K. A Review on Bone Mineral Density Loss in Total Knee Replacements Leading to Increased Fracture Risk. Clin Rev Bone Miner Metab 2017;15:162-74. [PMID: 29213219 DOI: 10.1007/s12018-017-9238-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
43 Covic A, Vervloet M, Massy ZA, Torres PU, Goldsmith D, Brandenburg V, Mazzaferro S, Evenepoel P, Bover J, Apetrii M, Cozzolino M. Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population. Lancet Diabetes Endocrinol 2018;6:319-31. [PMID: 29050900 DOI: 10.1016/S2213-8587(17)30310-8] [Cited by in Crossref: 75] [Cited by in F6Publishing: 78] [Article Influence: 15.0] [Reference Citation Analysis]
44 Rapposelli S, Gambari L, Digiacomo M, Citi V, Lisignoli G, Manferdini C, Calderone V, Grassi F. A Novel H2S-releasing Amino-Bisphosphonate which combines bone anti-catabolic and anabolic functions. Sci Rep 2017;7:11940. [PMID: 28931828 DOI: 10.1038/s41598-017-11608-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
45 Hoffmeister E. Longer-Term Effects of Bisphosphonate Therapy on Trabecular Microstructure. Lippincott's Bone and Joint Newsletter 2017;23:73-75. [DOI: 10.1097/01.bonej.0000521054.45932.78] [Reference Citation Analysis]
46 Erviti J, Gorricho J, Saiz LC, Perry T, Wright JM. Rethinking the Appraisal and Approval of Drugs for Fracture Prevention. Front Pharmacol 2017;8:265. [PMID: 28555109 DOI: 10.3389/fphar.2017.00265] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
47 Bover J, Bailone L, López-báez V, Benito S, Ciceri P, Galassi A, Cozzolino M. Osteoporosis, bone mineral density and CKD–MBD: treatment considerations. J Nephrol 2017;30:677-87. [DOI: 10.1007/s40620-017-0404-z] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 7.8] [Reference Citation Analysis]
48 Anagnostis P, Paschou SA, Mintziori G, Ceausu I, Depypere H, Lambrinoudaki I, Mueck A, Pérez-López FR, Rees M, Senturk LM, Simoncini T, Stevenson JC, Stute P, Trémollieres FA, Goulis DG. Drug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis: EMAS position statement. Maturitas 2017;101:23-30. [PMID: 28539165 DOI: 10.1016/j.maturitas.2017.04.008] [Cited by in Crossref: 79] [Cited by in F6Publishing: 65] [Article Influence: 15.8] [Reference Citation Analysis]
49 Oliveira L, Souza R, Barbosa A, Seragioli F, Quintao G, Horiy D, Giorgi R, Azevedo E. PERFIL CLÍNICO COMPARATIVO ENTRE PACIENTES EM USO DE ÁCIDO ZOLEDRÔNICO E ALENDRONATO PARA TRATAMENTO DE OSTEOPOROSE. Revista Brasileira de Reumatologia 2017;57:S78-S79. [DOI: 10.1016/j.rbr.2017.07.018] [Reference Citation Analysis]